Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:17:59.913Z.
Calculation as of: 2026-10-06T16:17:59.913Z.
Quote observation: 2026-10-06T16:15:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c752279377b025acf72c3dd079155b3811244be546b74823e0a9f28be94cffb5
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Nano-X Imaging Ltd.
Market Cap
$43.97M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.35M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.62M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$43.14M
Operating Cash Flow Yield
N/A
TTM Avg
11.87%
3Y Avg
9.02%
5Y Avg
6.85%
Market Cap
$45.09M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$42.61M
Operating Cash Flow Yield
2.58%
TTM Avg
2.14%
3Y Avg
3.12%
5Y Avg
3.12%
Market Cap
$40.67M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$40.28M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nano-X Imaging Ltd. (NNOX) | $43.97M | N/A | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $44.05M | N/A | N/A | N/A | N/A |
| DarioHealth Corp. (DRIO)vs › | $44.35M | N/A | N/A | N/A | N/A |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $44.62M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $43.14M | N/A | 11.87% | 9.02% | 6.85% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.09M | N/A | N/A | N/A | N/A |
| Precipio, Inc. (PRPO)vs › | $42.61M | 2.58% | 2.14% | 3.12% | 3.12% |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.67M | N/A | N/A | N/A | N/A |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | N/A | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $39.96M | N/A | 4.07% | 3.32% | 3.32% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
